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Abstract
Background: The objective of the study was to describe the frequencies of health-care utilization by people with
substance use disorder (SUD), including contacts with general practitioners (GP), psychiatrists, emergency
departments (ED) and hospital admissions and to compare this frequency to the general population.
Methods: Data from the national register of people who were in treatment for SUD between 2011 and 2014 was
linked to health care data from the Belgian health insurance (N = 30,905). Four comparators were matched on age,
sex and place of residence to each subject in treatment for SUD (N = 123,620). Cases were further divided in five
mutually exclusive categories based on the main SUD (opiates, crack/cocaine, stimulants, cannabis and alcohol). We
calculated the average number of contacts with GP, psychiatrists and ED, and hospital admissions per person over a
ten year period (2008–2017), computed descriptive statistics for each of the SUD and used negative binomial
regression models to compare cases and comparators.
Results: Over the ten-year period, people in treatment for SUD overall had on average 60 GP contacts, 3.9 psychiatrist
contacts, 7.8 visits to the ED, and 16 hospital admissions. Rate ratios, comparing cases and corresponding comparators,
showed that people in treatment for SUD had on average 1.9 more contacts with a GP (95 % CI 1.9-2.0), 7.4 more
contacts with a psychiatrist (95 % CI 7.0-7.7), 4.2 more ED visits (95 % CI 4.2–4.3), and 6.4 more hospital admissions
(95 % CI 6.3–6.5).
Conclusions: The use of health services for people with SUD is between almost two (GP) and seven times (psychiatrist)
higher than for comparators. People in treatment for alcohol use disorders use health care services more frequently
than people in treatment for other SUD. The use of health services remained stable in the five years before and after
the moment people with SUD entered into treatment for SUD. The higher use of primary health care services by
people with SUD might indicate that they have higher health care needs than comparators.
Keywords: Substance Use Disorders, Health care services, Health care service providers, Belgium, Cohort study,
Epidemiology
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Background
People with substance use disorders (SUD) are known to
have poor health outcomes and increased risk of prema-
ture death. In Belgium, previous research found that be-
ing in treatment for SUD increased all-cause mortality
risk nearly elevenfold for users of illicit drugs, and seven-
fold for users of licit drugs [1]. In 2017 in Belgium, alco-
hol was estimated to account for 5.3 % of all deaths and
6.1 % of the disability-adjusted life-years (DALYs) [2]. In
the same year (2017), illicit drugs were estimated to con-
tribute to 0.25 % of all deaths and to 0.81 % of the
DALYs. People with SUD have a higher risk of contract-
ing cancers, cardiovascular, respiratory and liver disor-
ders [3, 4] or infectious diseases such as tuberculosis [5],
hepatitis C [6] or diseases due to the human immuno-
deficiency virus (HIV) [7], and also more oral health
problems [8].
Notwithstanding these high needs, people with SUD
face many obstacles when in need for general health care
treatment: lack of financial means, lack of knowledge
about the availability of help, lack of trust in treatment,
and stigmatizing attitudes among health professionals
[9–12]. For example, one of the reasons for the low
number of people with SUD treated for Hepatitis C
Virus (HCV) is some clinicians considering them as dif-
ficult to treat because of existing social and psycho-
logical barriers and concerns about reinfection [13–15].
However, recent studies in Belgium [16, 17] have shown
that there is no significant difference in outcome be-
tween HCV treatment of people with SUD and the gen-
eral population. Several other national and international
studies have reported that treatment barriers not only
exist in the case of infectious diseases such as hepatitis
C or HIV [6, 7] but also for general health care [18, 19],
hospital care [18, 20], dental health care [8], palliative
care [21], and preventive measures such as contraception
[22] or for access to pharmacies [18]. Although scientific
literature on these obstacles is lacking for people with
SUD in Belgium, there is no reason to believe that they
face less barriers for these health problems than people
in other parts of the world.
Because of these obstacles, previous studies have con-
cluded that people with SUD heavily rely on emergency
departments for general healthcare problems [23, 24]. A
meta-analysis in 2019 revealed that people with SUD have
on average 4.8 times more episodes in emergency depart-
ments than the general population [25]. The same review
also identified several gaps in the evidence such as the fact
that little is known about the health care use of people
with cannabis use disorders, MDMA or amphetamine use
disorders, powder cocaine use disorders, as well as the
lack of knowledge about the use of primary health care by
people with SUD [25]. It remains unclear whether the
higher use of ED visits and hospitalizations are indeed the
result of postponed care due to structural, financial and
social obstacles, or if the needs for PWUD are generally
much higher, which could also result in more frequent
use of primary health care.
To address these gaps, the primary objective of this
study is to describe the frequencies of health-care
utilization by people with SUD, more specifically con-
tacts with general practitioners (GP), psychiatrists, emer-
gency departments (ED) and hospital admissions, for
people with alcohol use disorders, cannabis use disor-
ders, disorders related to the use of stimulants other
than crack/cocaine, cocaine use disorders and opiate use
disorders. The second objective is to compare the fre-
quency of health-care utilization of these people to the
general population in Belgium.
Methods
Data for the current study was generated through the link-
age and matching of two existing Belgian national health
and population registers: (1) the Belgian Treatment De-
mand Indicator database (TDI) with information on
socio-demographic variables and substances for which
treatment was sought at the start of the treatment episode
for people in treatment for SUD, covering almost all spe-
cialized drug treatment centers and by around one third
of the general or psychiatric hospitals [26], and (2) the
InterMutualistic Agency database (IMA, [27]) with data
on reimbursed health care services, gathered through the
seven Belgian health insurance agencies. The data that
was used from this database consists of contacts with gen-
eral practitioners, psychiatrists, ED and admissions to the
hospital, and spanned a period between 1 January 2008
and 31 December 2017. The full IMA-database covers
99 % of the people living in Belgium, as health care insur-
ance is mandatory [28].
The Belgian National Identification Number (NIN)
was used to link both databases. All patients registered
in TDI with a NIN who started a treatment for SUD be-
tween 2011 and 2014 and who could be identified in the
IMA database were considered eligible subjects for this
study (n = 30,905). For those with multiple episodes the
first treatment episode in TDI was selected, in line with
the TDI-IMA protocol [28]. Cases were further divided
in five mutually exclusive categories: people in treatment
for opiate use disorders (some of which were also in
treatment for other substances), people in treatment for
crack/cocaine use disorders who were not in treatment
for opiates, people in treatment for stimulant use disor-
ders (mainly MDMA and amphetamines) who were not
in treatment for opiates or crack/cocaine, people in
treatment for cannabis use disorders with or without
alcohol use disorders who were not in treatment for opi-
ates, crack/cocaine or stimulants, and people in treat-
ment for only alcohol use disorders.
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Furthermore, there were 3,198 people in treatment for
other substances, who were excluded from the analysis,
which gives a total of 27,707 cases.
A group of comparators who had not been in treat-
ment for SUD between 2011 and 2014 was selected from
the general population through the IMA database [28].
Four comparators were matched on age, sex and munici-
pality of residence to each case in treatment for SUD.
Sex and age were considered to be basic matching vari-
ables. The potential confounding of municipality of resi-
dence is related to regional differences in health care
regulation, health care seeking and access to specialized
medical health care for SUD as well as other differences
that might be present, for instance socio-economic sta-
tus of the patients by region.
For people with SUD as a whole as well as for each of
the five patient categories and the corresponding com-
parators and for men and women separately, we calcu-
lated the median and average number of contacts with
primary care physicians, psychiatrists and ED, and hos-
pital admissions per person over the ten year period. We
computed descriptive statistics for each of these groups
and used negative binomial regression models to com-
pare cases and comparators. This analysis models the
log of the expected count (i.e., number of visits) as a lin-
ear function of cases versus comparators. The coeffi-
cients obtained were exponentiated to get rate ratios
(with corresponding 95 % confidence intervals). For the
graphical representation of the average use of each out-
come variable data were recalibrated towards the day
people with SUD entered into treatment. Graphs repre-
sent the results of the outcome variable five years before
and five years after this day. In this way, they illustrate
the evolution over time per month for each category of
patients and corresponding comparators.
Data analysis was done using SAS software version 9.3
(SAS Institute Inc., Cary, NC). The reporting of this
study conforms to the STROBE guidelines [29].
Results
As shown in Table 1, almost one in three cases was in
treatment for alcohol use disorders only, one in five was
in treatment for cannabis or opiate use disorders,
whereas 14 % was in treatment for cocaine use disorders
and 8.6 % for stimulant use disorders.
People in treatment for alcohol use disorders were older,
were more likely to have been in treatment for SUD be-
fore and relied mainly on inpatient services. People in
treatment for disorders related to street drugs were youn-
ger and most often supported by outpatient services.
Over the ten-year period 2008–2017, people in treat-
ment for SUD overall had on average 60 GP contacts,
3.9 psychiatrist contacts, 7.8 visits to the ED, and 16 hos-
pital admissions (Table 2).
Rate ratios, comparing cases and corresponding com-
parators, showed that people in treatment for SUD had
on average 1.9 more contacts with a GP (95 % CI 1.9-
2.0), 7.4 more contacts with a psychiatrist (95 % CI 7.0-
7.7), 4.2 more ED visits (95 % CI 4.2–4.3), and 6.4 more
hospital admissions (95 % CI 6.3–6.5) (Table 3).
Rate ratios per SUD category ranged for GP contacts
between 1.6 (cannabis, 95 %CI 1.6–1.6) and 2.6 (opiates,
95 %CI 2.5–2.7), for psychiatrist contacts between 5.6
(cannabis, 95 %CI 4.9–6.3) and 7.7 (alcohol, 95 %CI 7.1–
8.3), for contacts with ED between 2.8 (cannabis, 95 %CI
2.7–2.8) and 5.7 (alcohol, 95 %CI 5.6–5.9), and for hos-
pital admissions between 4.6 (opiates, 95 %CI 4.4–4.8)
and 7.6 (alcohol, 95 %CI 7.3–7.8).
Women with SUD were using health care services
more than men, with rate ratios ranging between 1.1
(ED, 95 %CI 1.1–1.1) and 1.7 (hospital admissions, 95 %
CI 1.6–1.7).
Figure 1 illustrates the monthly proportion of people
in treatment for SUD in contact with GP for each cat-
egory of SUD and their comparators. It reflects the data
of Table 2 as monthly averages, e.g. people with alcohol
use disorders have over the 120 months period on aver-
age 65 contacts with a GP, which give an average of ap-
proximately 0.5 contacts per month per person.
Figures 2, 3 and 4 give a similar representation of the
proportion of people in treatment for SUD and compar-
ators in contact with psychiatrists, the ED and by hos-
pital admissions, respectively.
Discussion
Use of health care services by people with SUD is high.
Our results for ED and hospitalizations episodes are in
line with the results of previous studies [25]. At the same
time, our study gives a better understanding of the num-
ber of contacts with general practitioners by people with
SUD. People in treatment for SUD have between 1.6 and
1.9 times more contacts with a GP than their compara-
tors, except for people in treatment for opiate use disor-
ders who have on average 2.6 times more contacts with
their GP than their respective comparators. The reason
for this higher frequency might be that many of them
are on substitution treatment for which they have to
consult a GP. For all other considered health service
providers, people with alcohol use disorders had more
frequent contacts than people with disorders related to
street drugs and the comparators. This last observation
is in contrast to findings from a previous study where
people with alcohol use disorders were found to use less
health care services than the general population [30].
Overall, people with SUD had a higher use of primary
care than acute health care, which is in line with findings
from the few number of studies who reported on this
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[31, 32]. Compared to the comparators, the differences
in use of health services between people in treatment for
disorders related to cannabis, stimulants and crack/co-
caine are minimal for contacts with the GP, and not
significant for hospitalizations and contacts with psychi-
atrists. Only people in treatment for cannabis use disor-
ders have significantly less contacts with the ED than
the comparators compared to people with disorders re-
lated to stimulants and crack/cocaine.
Interestingly, as shown by the Figs. 1, 2, 3 and 4, there
is little difference in the number of contacts with the
specific health service providers over time within each
category of SUD. Indeed, the use of health services
remains quite stable in the five years before and after the
moment people with SUD entered into treatment. Of
course, this does not provide insights in individual vari-
ation over time, but it remains interesting to see that
this level of health care use was that stable. We could
not find other studies to support or contradict this
finding.
One reason for the high use of general health services
might be that the data is based on the first episode in
TDI between 2011 and 2014, with between 36.6 % (can-
nabis) and 80.7 % (opiates) of the cases who had been
already in treatment for SUD before, meaning that they
might have had already serious substance use related
Table 1 Descriptive statistics people in treatment for substance use disorder by main product in Belgium (2011-2014)
opiates crack/cocaine stimulants cannabis alcohol
Sex (N missing = 9) Men N 4502 3420 1998 4924 6207
% 79.1% 80.9% 74.8% 85.3% 66.5%
Women N 1188 807 675 852 3125
% 20.9% 19.1% 25.3% 14.8% 33.5%
Age (N missing = 2365) <20 N 68 177 308 1363 26
% 1.2% 4.4% 12.3% 25.8% 0.3%
20-29 N 1568 1737 1038 2236 388
% 28.5% 43.4% 41.4% 42.3% 4.7%
30-39 N 2153 1516 839 1125 1322
% 39.2% 37.9% 33.4% 21.3% 16.0%
40-49 N 1380 480 260 435 2690
% 25.1% 12.0% 10.4% 8.2% 32.6%
50-59 N 299 83 59 114 2686
% 5.4% 2.1% 2.4% 2.2% 32.5%
>60 N 25 10 6 11 1147
% 0.5% 0.2% 0.2% 0.2% 13.9%
Region (N missing = 0) Flanders N 3096 3345 2604 4785 6298
% 54.4% 79.1% 97.4% 82.8% 67.5%
Wallonia N 1815 602 43 768 2591
% 31.9% 14.2% 1.6% 13.3% 27.8%
Brussels N 780 280 26 227 447
% 13.7% 6.6% 1.0% 3.9% 4.8%
In treatment before (N missing = 1768) No N 965 1969 1215 3547 3295
% 19.3% 49.1% 48.6% 63.4% 36.6%
Yes N 4035 2042 1283 2045 5709
% 80.7% 50.9% 51.4% 36.6% 63.4%
Type treatment setting (N missing = 0) Inpatient N 2341 1675 761 1506 7918
% 41.1% 39.6% 28.5% 26.1% 84.8%
Outpatient N 3350 2552 1912 4274 1418
% 58.9% 60.4% 71.5% 73.9% 15.2%
Total N 5691 4227 2673 5780 9336
% 18.4% 13.7% 8.6% 18.7% 30.2%
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and general health care problems before the day on
which they were registered in TDI. We also acknowledge
the fact that the proportion of people with hospital ad-
missions in the months after start of treatment for alco-
hol cases (Fig. 4) shows a slower decline than for other
substance categories, although at this time we cannot
provide a good explanation for this.
A previous study concluded that the higher use of
health care services by PWUD, compared to compara-
tors from the general population, reflects the greater
need for treatment, but that it does not necessarily rep-
resent good health-care access and that this might reflect
a pattern where primary and preventative health care is
poor and PWUD rely mainly on unplanned health care
[25]. The current study gives a more nuanced picture.
Indeed, PWUD make more use of ED and are more ad-
mitted to hospitals, but also the use of GPs is signifi-
cantly higher than for comparators. This higher use of
primary health care could underline the presence of high
needs, as does the substantial higher use of psychiatric
care. At the same time, the current study cannot con-
clude that access for PWUD is sufficient or that existing
care services answer the needs of PWUD, since we only
analyzed the use of health care and not outcome of care.
For instance, postponing to seek and receive health care
is likely to increase the risk of developing complications
Table 2 Median and mean number of contacts/episodes with health provider/service (standard deviation (sd)) per 10 person-years
for people in treatment for substance use disorders between 2011 and 2014 and their comparators in Belgium, overall, by substance
and by sex (2008-2017)
Contacts with GPa Contacts with psychiatrist Contacts with EDa Hospital admissions
n median mean sd median mean sd median mean sd median mean sd
overall control 123620 23 30.8 33.3 0 0.5 1.2 1 1.9 2.9 1 2.5 9.4
case 30905 43 59.9 68.4 0 3.9 10.8 5 7.8 11.9 6 16.0 30.8
opiates control 22764 19 26.1 29.4 0 0.6 4.5 1 2.1 3.3 1 2.2 9.7
case 5691 44 68.5 82.7 0 3.9 14.1 5 7.9 10.8 5 10.1 21.4
cocaine/crack control 16908 20 26.7 27.9 0 0.4 3.7 1 1.9 2.8 1 2.1 10.0
case 4227 36 47.0 49.1 0 2.7 7.8 5 7.0 8.4 4 10.6 23.1
stimulants control 10692 23 29.1 27.5 0 0.4 3.1 1 1.8 2.6 1 2.2 8.7
case 2673 40 53.3 55.7 0 2.5 8.0 4 5.8 6.5 4 11.9 25.0
cannabis control 23120 19 24.8 25.2 0 0.4 2.9 1 2.0 2.9 1 1.8 6.7
case 5780 31 39.6 43.1 0 2.1 6.5 3 5.6 8.3 3 8.9 21.9
alcohol control 37344 29 38.0 39.3 0 0.7 5.1 1 1.6 2.7 1 3.2 10.4
case 9336 51 64.7 62.7 1 5.0 11.2 6 9.1 14.2 12 24.2 38.4
women control 32268 33 41.6 40.6 0 0.7 4.4 1 1.7 3.0 2 3.4 9.5
case 8067 62 81.9 84.1 1 4.9 11.8 6 8.6 12.7 11 22.5 13.3
men control 91316 20 26.9 29.3 0 0.5 4.1 1 1.9 2.9 1 2.2 9.4
case 22829 37 52.1 60.1 0 3.5 10.4 5 7.6 11.6 5 13.7 27.8
aGP general practitioner, ED emergency department
Table 3 Rate ratios (RR) (with standard error (SE) and 95 % confidence interval (CI)) of use of health provider/service for people in
treatment for substance use disorders between 2011 and 2014 versus comparators in Belgium, overall, by substance and by sex
(2008–2017)
Contacts with GPa Contacts with psychiatrist Contacts with EDa Hospital admissions
RR SE 95% CI RR SE 95% CI RR SE 95% CI RR SE 95% CI
Overall 1.9 0.01 1.9-2.0 7.4 0.17 7.0-7.7 4.2 0.03 4.2–4.3 6.4 0.06 6.3–6.5
Opiates 2.6 0.04 2.5–2.7 6.7 0.40 5.9–7.5 3.7 0.06 3.5–3.8 4.6 0.10 4.4–4.8
Cocaine 1.8 0.03 1.7–1.8 6.5 0.40 5.7–7.4 3.6 0.07 3.5–3.8 5.0 0.12 4.8–5.3
Stimulants 1.8 0.03 1.8–1.9 7.0 0.61 5.9–8.3 3.3 0.08 3.1–3.5 5.3 0.16 5.0-5.6
Cannabis 1.6 0.02 1.6–1.6 5.6 0.30 4.9–6.3 2.8 0.05 2.7–2.8 4.9 0.10 4.7–5.1
Alcohol 1.7 0.02 1.7–1.7 7.7 0.30 7.1–8.3 5.7 0.05 5.6–5.9 7.6 0.11 7.3–7.8
Women (vs. men) 1.6 0.02 1.5–1.6 1.4 0.04 1.3–1.5 1.1 0.02 1.1–1.2 1.7 0.03 1.6–1.7
aGP general practitioner, ED emergency department
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[33]. Even if PWUD attend more often than comparators
a GP, it might still be that they wait much longer to seek
help, which might result in more intense use of health
care services.
The current study has several limitations, some of
which have already been mentioned in previous articles
[1, 6, 28]. Three out of four episodes in TDI are regis-
tered with a NIN. This means that for one quarter of all
episodes it was impossible to identify the person with
SUD and to extract their data from the IMA-database.
People who are registered without NIN are known to be
more in treatment in a psychiatric unit of a general hos-
pital, in treatment for opiates, in treatment in Wallonia
and to be non-Belgian [34], but as shown by a previous
study, there is little evidence that patient characteristics
have a major impact on the registration with a NIN [34].
Fig. 1 Monthly proportion of people in treatment for substance use disorders between 2011 and 2014 and comparators in contact with general
practitioner in the five years before and after the day of start treatment, by substance in Belgium (2008-2017)
Fig. 2 Monthly proportion of people in treatment for substance use disorders between 2011 and 2014 and comparators in contact with a
psychiatrist in the five years before and after the day of start treatment, by substance in Belgium (2008-2017)
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Moreover, outreach services and harm reduction ini-
tiatives are not covered by TDI, nor are GPs who are
considered to play a major role in detecting and man-
aging SUD directly [26]. This means that people with
SUD who are only treated by GPs are not included in
the database. However, for all people registered in TDI,
data about their consultations to GPs are registered in
IMA. As a result the exact denominator of all people
who are in treatment for SUD in Belgium is unknown,
but the proportion of them who are registered in TDI
can be understood as the large majority. Further re-
search will look into this denominator. Because health
insurance is mandatory in Belgium, for almost all people
who are registered in TDI with a NIN, data are available
in IMA. As such, the reported results give a reliable un-
derstanding of the use of services for general healthcare
Fig. 3 Monthly proportion of people in treatment for substance use disorders between 2011 and 2014 and comparators in contact with
emergency department in the five years before and after the day of start treatment, by substance in Belgium (2008-2017)
Fig. 4 Monthly proportion of people in treatment for substance used disorders between 2011 and 2014 and comparators with hospital admissions in
the five years before and after the day of start treatment, by substance in Belgium (2008-2017)
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problems by people with SUD in Belgium who are regis-
tered in TDI with a NIN.
Finally, the use of register data for a vast and diversi-
fied group of people in treatment for SUD allows a bet-
ter understanding of the number of contacts with health
care service providers. However, the relatively limited
evolution over time, and the fact that almost 60 % of the
cases had been in specialized treatment for SUD before,
supports the idea that the development of SUD is a
long-term process. Further research should thus take a
longer time period into consideration to describe earlier
phases in the use of general health care services leading
to specialized treatment of SUD.
Conclusions
People with SUD go almost twice as often to the GP as
comparators and more than seven times more often to
the psychiatrist. They are also more than six times more
frequently admitted to the hospital than comparators.
People in treatment for alcohol use disorders make sig-
nificantly more use of health services and health service
providers than people in treatment for disorders related
to street drugs. The use of health services remains quite
stable in the five years before and after the moment
people with SUD entered into treatment for their SUD.
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